journal article·2022-04

All‐In‐One Biomimetic Nanoplatform Based on Hollow Polydopamine Nanoparticles for Synergistically Enhanced Radiotherapy of Colon Cancer

Liuyun Gong, Yujie Zhang, Jing Zhao, Yilei Zhang, Kangsheng Tu, Lianying Jiao, Qiuran Xu, Mingzhen Zhang, Suxia Han

Small· Volume 18· Issue 14
Publisher page

Abstract

Abstract Even though radiotherapy is the most important therapeutic strategy for colon cancer treatment, there is an enormous demand to improve radiosensitivity in solid tumor destruction. For this purpose, a biomimetic nanoplatform based on hollow polydopamine nanoparticles (HP) with homologous targeting and pH‐responsive drug release properties is designed. In this work, HP is constructed by using a chelation competition‐induced polymerization strategy and then modified with the cancer cell membrane. Hollow polydopamine integrated with Pt nanoparticles (Pt@HP) has a catalase‐like activity, which can be used to trigger endogenous H2O2 into O2, relieving hypoxia of the tumor microenvironment (TME). With mesoporous shells and large cavities, Pt@HP shows efficient apoptin100–109 (AP) and verteporfin (VP) loading to form AVPt@HP@M. Under X‐ray irradiation, AVPt@HP@M exerts a radiosensitization effect via multiple strategies, including relieving hypoxia (Pt NPs), enhancing tumor apoptosis (AP), and X‐ray‐induced photodynamic therapy (X‐PDT) (VP). Further metabonomics analysis shows that the specific mechanism of the AVPt@HP@M is through influencing purine metabolism. Without appreciable systemic toxicity, this nanoplatform highlights a new strategy for effective radiosensitization and provides a reference for treating malignant tumors.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Advanced Photocatalysis Techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Radiotherapy the First Affiliated Hospital Xi'an Jiaotong University Xi'an Shaanxi 710061 China

School of Basic Medical Sciences Xi'an Key Laboratory of Immune Related Diseases Xi'an Jiaotong University Xi'an Shaanxi 710061 China

Key Laboratory of Environment and Genes Related to Diseases Xi'an Jiaotong University Ministry of Education Xi'an Shaanxi 710061 China

Department of Radiotherapy the First Affiliated Hospital Soochow University Suzhou Jiangsu 215000 China

Department of Hepatobiliary Surgery the First Affiliated Hospital of Xi'an Jiaotong University Xi'an Shaanxi 710061 China

Laboratory of Tumor Molecular Diagnosis and Individualized Medicine of Zhejiang Province Zhejiang Provincial People's Hospital Affiliated People's Hospital Hangzhou Medical College Hangzhou Zhejiang 310014 China

Research Center of Diagnosis and Treatment Technology for Hepatocellular Carcinoma of Zhejiang Province Hangzhou Zhejiang 310009 China

Funding

National Natural Science Foundation of China

References (77)

Show source-provided references
1. 10.3322/caac.2157710.3322/caac.21577 ↗
2. 10.3389/fchem.2021.68630310.3389/fchem.2021.686303 ↗
3. 10.1186/s40425-018-0377-z10.1186/s40425-018-0377-z ↗
4. 10.1038/nrclinonc.2015.21810.1038/nrclinonc.2015.218 ↗
5. 10.1002/adfm.20191039510.1002/adfm.201910395 ↗
6. 10.1016/j.ejca.2008.12.02110.1016/j.ejca.2008.12.021 ↗
7. 10.1200/JCO.2007.12.787810.1200/JCO.2007.12.7878 ↗
8. 10.1038/s41392-020-0150-x10.1038/s41392-020-0150-x ↗
9. 10.2147/IJN.S16496710.2147/IJN.S164967 ↗
10. 10.1021/acsnano.0c0432410.1021/acsnano.0c04324 ↗
11. 10.1039/C6CS00616G10.1039/C6CS00616G ↗
12. 10.3389/fmed.2019.0011710.3389/fmed.2019.00117 ↗
13. 10.2147/IJN.S29043810.2147/IJN.S290438 ↗
14. 10.7150/thno.3286710.7150/thno.32867 ↗
15. 10.3390/cancers1201024210.3390/cancers12010242 ↗
16. 10.1002/adma.20200729310.1002/adma.202007293 ↗
17. 10.1002/advs.20200185310.1002/advs.202001853 ↗
18. 10.1016/j.ejphar.2009.06.06810.1016/j.ejphar.2009.06.068 ↗
19. 10.1007/s10495-005-0930-310.1007/s10495-005-0930-3 ↗
20. 10.1073/pnas.94.11.584310.1073/pnas.94.11.5843 ↗
21. 10.1128/JVI.74.15.7072-7078.200010.1128/JVI.74.15.7072-7078.2000 ↗
22. 10.1038/sj.onc.120722410.1038/sj.onc.1207224 ↗
23. 10.7150/thno.4157810.7150/thno.41578 ↗
24. 10.7150/thno.1614110.7150/thno.16141 ↗
25. 10.1002/wnan.154110.1002/wnan.1541 ↗
26. 10.2147/IJN.S14046210.2147/IJN.S140462 ↗
27. 10.1002/adma.20180042610.1002/adma.201800426 ↗
28. 10.1002/adma.20180199310.1002/adma.201801993 ↗
29. 10.1002/smll.20120106410.1002/smll.201201064 ↗
30. 10.1016/j.biomaterials.2020.11976110.1016/j.biomaterials.2020.119761 ↗
31. 10.7150/thno.3806910.7150/thno.38069 ↗
32. 10.1016/j.biomaterials.2019.11963610.1016/j.biomaterials.2019.119636 ↗
33. 10.1016/j.apsb.2019.01.01110.1016/j.apsb.2019.01.011 ↗
34. 10.1080/10717544.2021.193418810.1080/10717544.2021.1934188 ↗
35. 10.1038/s41580-019-0108-410.1038/s41580-019-0108-4 ↗
36. 10.1002/ijc.3192910.1002/ijc.31929 ↗
37. 10.1016/j.cclet.2019.12.00110.1016/j.cclet.2019.12.001 ↗
38. 10.1021/acs.chemmater.7b0227410.1021/acs.chemmater.7b02274 ↗
39. 10.1021/acs.nanolett.7b0302110.1021/acs.nanolett.7b03021 ↗
40. 10.1021/jacs.7b1103610.1021/jacs.7b11036 ↗
41. 10.1002/smll.20170062310.1002/smll.201700623 ↗
42. 10.1080/10717544.2017.137731610.1080/10717544.2017.1377316 ↗
43. 10.1002/adtp.20190008310.1002/adtp.201900083 ↗
44. 10.1021/acsami.0c1885310.1021/acsami.0c18853 ↗
45. 10.1186/s13045-020-01030-w10.1186/s13045-020-01030-w ↗
46. 10.1039/C9SC00985J10.1039/C9SC00985J ↗
47. 10.1016/j.cclet.2020.03.03910.1016/j.cclet.2020.03.039 ↗
48. 10.1038/nnano.2015.1710.1038/nnano.2015.17 ↗
49. 10.1016/j.nano.2011.01.01410.1016/j.nano.2011.01.014 ↗
50. 10.3390/biomedicines903032210.3390/biomedicines9030322 ↗
51. 10.1021/acs.molpharmaceut.8b0095910.1021/acs.molpharmaceut.8b00959 ↗
52. 10.1016/j.ijrobp.2004.03.00510.1016/j.ijrobp.2004.03.005 ↗
53. 10.2217/nnm-2019-014010.2217/nnm-2019-0140 ↗
54. 10.1089/met.2019.003810.1089/met.2019.0038 ↗
55. 10.1002/cam4.308610.1002/cam4.3086 ↗
56. Cai A. · Clin. Lab. · 2017 · 63 · 73
57. 10.1021/acsbiomaterials.0c0047210.1021/acsbiomaterials.0c00472 ↗
58. 10.1016/j.cclet.2019.01.00310.1016/j.cclet.2019.01.003 ↗
59. 10.1038/s41419-019-1989-z10.1038/s41419-019-1989-z ↗
60. 10.1158/2326-6066.CIR-19-015910.1158/2326-6066.CIR-19-0159 ↗
61. 10.1126/scisignal.aac541810.1126/scisignal.aac5418 ↗
62. 10.1016/j.dnarep.2007.02.00610.1016/j.dnarep.2007.02.006 ↗
63. 10.1158/1535-7163.MCT-14-076510.1158/1535-7163.MCT-14-0765 ↗
64. 10.18632/oncotarget.1102310.18632/oncotarget.11023 ↗
65. 10.1038/sj.emboj.760046910.1038/sj.emboj.7600469 ↗
66. 10.1093/nar/gkz114610.1093/nar/gkz1146 ↗
67. 10.1093/nar/gkv149910.1093/nar/gkv1499 ↗
68. Dong Y. · Am. J. Cancer Res. · 2019 · 9 · 1469
69. 10.1002/adfm.20170408910.1002/adfm.201704089 ↗
70. 10.1152/japplphysiol.00898.201110.1152/japplphysiol.00898.2011 ↗
71. 10.1021/ja400805b10.1021/ja400805b ↗
72. 10.3390/cancers1315383310.3390/cancers13153833 ↗
73. 10.1038/nrc.2016.8510.1038/nrc.2016.85 ↗
74. 10.1038/onc.2016.20610.1038/onc.2016.206 ↗
75. 10.1089/jmf.2016.386510.1089/jmf.2016.3865 ↗
76. 10.1126/science.115224110.1126/science.1152241 ↗
77. 10.1073/pnas.142300911210.1073/pnas.1423009112 ↗